Buy the full study
Summary of our market study
to understand this market
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Synthèse du marché
1.1 Scope of the study
Pharmacies are companies in the healthcare sector that trade in medicines or manufacture them themselves and sell them to private customers or supply them to other companies in the healthcare sector. The core tasks include supplying the population with medicines, providing advice on medicines and medicine, as well as pharmaceutical services and solving problems related to drug therapy.
The market for pharmacies is highly fragmented and includes small family businesses through to chains and groupings. With the deiwlization of online commerce, some pharmacies have focused on their online presence and online shipping.
Globally, the market for pharmacies and pharmaceuticals is in steady growth. Between 2001 and 2021, the market has grown at a compound annual growth rate (CAGR ) of 6.25%[IQVIA]. The United States represents the largest market for pharmaceuticals, followed by emerging economies such as Brazil, India, Russia. Europe is in third place in terms of annual sales[Astrazeneca].
In Germany, the market is also in steady growth. Since 2010 until 2021, German pharmacies have been able to generate an average annual sales growth of 3.44% (CAGR) [Bundesvereinigung Deutscher Apothekenverbände]. However, the number of public pharmacies has decreased by 2980 pharmacies between 2010 and 2021[Bundesvereinigung Deutscher Apothekenverbände].
The following market study deals with the market development of pharmacies, as well as with an analysis of the market structure and the competitive situation. From this, insightful information can be gained.
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Chemicals in the midst of a recovery, Bayer considers spin-offs - 09/11/2023
- Bayer sales: Close to 50 billion euros.
- Date on which Bayer will make a decision on the demerger of its entities: March 2024.
- Loss of value of the Bayer Group in five years: 40%.
- Bayer weighed down by falling glyphosate sales
Amazon exceeds 10 billion euros in sales in France - 27/09/2023
- Amazon sales in France in 2022: €10.5 billion.
- Sales growth since previous year: over 16%.
- Sales in France in 2021: €9 billion.
- Number of companies (VSEs and SMEs) selling on Amazon in France: over 16,000.
- Number of Amazon employees in France: Over 20,000.
- Amazon investments in France since 2010: Over €20 billion.
Bayer's glyphosate sales plummet - 25/07/2023
- Full-year sales for the current financial year are forecast at between 48.5 and 49.5 billion euros.
- Bayer acquired the US group Monsanto in 2018 for over 63 billion euros.
- Bayer shares have lost half their value since 2018.
Novartis raises its outlook and prepares to spin off Sandoz - 18/07/2023
Spin-off and IPO of Sandoz generics division planned for early fourth quarter
Pharmaceuticals Novartis acquires US-based Chinook Therapeutics for $3.5 billion - 13/06/2023
- Total consideration for Novartis acquisition of Chinook Therapeutics: up to $3.5 billion (€3.2 billion).
- Chinook Therapeutics is developing two drugs in advanced clinical trials for immunoglobulin A (IgA) nephropathy, a rare kidney disease.
- Up to three out of ten patients with this disease progress to kidney failure and require dialysis within ten years.
Johnson & Johnson values its products at over $40 billion - 25/04/2023
- Kenvue: new company resulting from the spin-off of Johnson & Johnson's (J & J) hygiene, beauty and consumer health division
- J & J to own approximately 92% of Kenvue after IPO
- Kenvue sales (fiscal year ending January 1): nearly $15 billion
- Kenvue: over 22,000 employees, 25 manufacturing sites, operations in over 165 countries.
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
The market of pharmacies | Germany
- Quels sont les chiffres sur la taille et la croissance du marché ?
- Quels leviers tirent la croissance du marché et leur évolution ?
- Quelles sont les dernières tendances sur ce marché ?
- Quel est le positionnement des entreprises sur la chaine de valeur ?
- Comment se différencient les entreprises du marché ?
- Accédez à la cartographie des entreprises et à leurs profils.
- Données issues de plusieurs dizaines de bases de données
Cette étude de marché est disponible en ligne et en pdf (38 p.)- Télécharger un exemple
- Une question sur cette étude : (+33) 9 70 46 55 00
5 reports pack (-15%) DE Germany
- 5 reports at €75.6 excluding VAT per study to choose from our German catalogue for 12 months
- Save 15% on additional studies purchased
- Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)
See the terms and conditions of the pack and the refund of unused credit.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
